Venoactive medications and the place of Daflon 500 mg in recent guidelines on the management of chronic venous disease

被引：0
|
作者：
Nicolaides, Andrew [1 ]
机构：
[1] Vasc Screening & Diagnost Ctr, 2 Kyriacou Matsi St, CY-2368 Nicosia, Cyprus
来源：
PHLEBOLYMPHOLOGY | 2009年 / 16卷 / 04期
关键词：
chronic venous disease; venoactive drugs; guidelines; Daflon; 500; mg;
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
Because the venous system is in many respects more complex than the arterial system, because chronic venous disease (CVD) is common in Western populations, and because both specialists and general practitioners have to deal with this disease, there is a need for practical support regarding CVD management in daily practice. This article summarizes the most recent guidelines regarding the place of venoactive drugs (VADs) such as Daflon 500 mg in the management of this disease. In addition, it makes suggestions regarding expected improvements in future guideline documents.
引用
收藏
页码：340 / 346
页数：7
相关论文
共 50 条
  • [21] New data on chronic venous disease: a new place for Cyclo 3® Fort
    Kakkos, Stavros K.
    Bouskela, Eliete
    Jawien, Arkadiusz
    Nicolaides, Andrew N.
    INTERNATIONAL ANGIOLOGY, 2018, 37 (01) : 85 - 92
  • [22] Treatment of chronic venous disease of the lower extremities: what's new in guidelines?
    Comerota, Anthony J.
    PHLEBOLYMPHOLOGY, 2009, 16 (04) : 313 - 320
  • [23] Management of chronic venous disease by primary care
    Lane, T. R. A.
    Sritharan, K.
    Herbert, J. R.
    Franklin, I. J.
    Davies, A. H.
    PHLEBOLOGY, 2013, 28 (06) : 299 - 304
  • [24] Recommendations for the medical management of chronic venous disease: The role of Micronized Purified Flavanoid Fraction (MPFF)
    Bush, Ronald
    Comerota, Anthony
    Meissner, Mark
    Raffetto, Joseph D.
    Hahn, Steven R.
    Freeman, Katherine
    PHLEBOLOGY, 2017, 32 : 3 - 19
  • [25] The Most Severe Stage of Chronic Venous Disease: An Update on the Management of Patients with Venous Leg Ulcers
    Nicolaides, Andrew N.
    ADVANCES IN THERAPY, 2020, 37 (SUPPL 1) : 19 - 24
  • [26] The Most Severe Stage of Chronic Venous Disease: An Update on the Management of Patients with Venous Leg Ulcers
    Andrew N. Nicolaides
    Advances in Therapy, 2020, 37 : 19 - 24
  • [27] Factors impeding venous return and their impact on the management of chronic venous disease
    Raiker, Ashna
    Labropoulos, Nicos
    PHLEBOLYMPHOLOGY, 2022, 29 (03) : 83 - 88
  • [28] The role of a multidisciplinary approach to the management of chronic venous disease
    Lobastov, Kirill
    Geroulakos, George
    Josnin, Matthieu
    Kan, Chung-Dann
    Nikolov, Nadelin
    Mezalek, Zoubida Tazi
    Dzhenina, Olga
    Poulou, Aikaterini
    Avgerinos, Efthymios
    Akulova, Anastasia
    PHLEBOLYMPHOLOGY, 2023, 30 (02) : 60 - 60
  • [29] Editor's Choice - Management of Chronic Venous Disease Clinical Practice Guidelines of the European Society for Vascular Surgery (ESVS)
    Wittens, C.
    Davies, A. H.
    Bwkgaard, N.
    Broholm, R.
    Cavezzi, A.
    Chastanet, S.
    De Wolf, M.
    Eggen, C.
    Giannoukas, A.
    Gohel, M.
    Kakkos, S.
    Lawson, J.
    Noppeney, T.
    Onida, S.
    Pittaluga, P.
    Thomis, S.
    Toonder, I.
    Vuylsteke, M.
    Kolh, P.
    de Borst, G. J.
    Chakfe, N.
    Debus, S.
    Hinchliffe, R.
    Koncar, I.
    Lindholt, J.
    de Ceniga, M. V.
    Vermassen, F.
    Verzini, F.
    De Maeseneer, M. G.
    Blomgren, L.
    Hartung, O.
    Kalodiki, E.
    Korten, E.
    Li, M. Lug
    Naylor, R.
    Nicolini, P.
    Rosales, A.
    EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 2015, 49 (06) : 678 - 737
  • [30] A systematic review assessing the quality of clinical practice guidelines in chronic venous disease
    Salim, Safa
    Tan, Matthew
    Geoghegan, Luke
    Belramman, Amjad
    Onida, Sarah
    Davies, Alun H.
    JOURNAL OF VASCULAR SURGERY-VENOUS AND LYMPHATIC DISORDERS, 2021, 9 (03) : 787 - +
12345